World’s leading generic drug maker
12 Nov, 2020

Well known 18 companies join the effort by Medicines Patent Pool to accelerate global access to effective COVID-19 treat.....

Read More
Indian pharma sunrise segment prognosis
02 Dec, 2020

New Delhi, Dec 28 (PTI) Nourished by increasing spending, improving accessibility and growing exports, India's pharm.....

Read More
Aurobindo Pharma signs pact with Covaxx
25 Dec 2020

Aurobindo Pharma Ltd and Covaxx, a US-based company, have entered into an exclusive license agreement to develop, commer.....

Read More
Aurobindo Pharma to stop molnupiravir tr

BENGALURU: Aurobindo Pharma Ltd wants to discontinue the late-stage trial of Merck & Co's experimental.....

Read More
Merck COVID-19 pill sparks calls for acc

The plan to roll out Merck & Co’s promising antiviral pill to treat COVID-19 risks repeating the inequities of.....

Read More
Indias Dr. Reddys open to making Pfizer

Dr. Reddy's Laboratories, one of a handful of Indian drug companies licensed to make a new COVID-19 pill developed b.....

Read More
Aurobindo Pharma subsidiary's plant gets

Aurobindo Pharma on Monday said the US health regulator has issued one observation after inspecting a plant owned by its.....

Read More
Aurobindo Pharma's arm to invest around

Aurobindo Pharma on Thursday said its wholly-owned arm, CuraTeQ Biologics, plans to invest around Rs 300 crore on capaci.....

Read More
U.S. Supreme Court rebuffs Novartis, all

The U.S. Supreme Court on Thursday turned down Novartis' bid to block the launch of generic versions of the company&.....

Read More
Aurobindo unit, Evive Biotech ink licens

Aurobindo Pharma on Wednesday said its unit has entered into a licensing pact with Evive Biotech to commercialise Ryzneu.....

Read More